肠易激综合征患者中乳糜泻的患病率。

The prevalence of celiac disease in patients with irritable bowel syndrome.

机构信息

Section for Gastroenterology, Medicine Clinic, Stord Helse-Fonna Hospital, Stord, Norway.

出版信息

Mol Med Rep. 2011 May-Jun;4(3):403-5. doi: 10.3892/mmr.2011.466. Epub 2011 Mar 22.

Abstract

The diagnosis of irritable bowel syndrome (IBS) is based on symptom assessment such as the Rome III criteria. It is sometimes difficult to clinically distinguish IBS from adult-onset celiac disease (CD). Individuals with CD presenting with relatively vague abdominal symptoms are at risk of been dismissed as having IBS. This study aimed to investigate the prevalence of patients with CD among those that fulfill the Rome III criteria for IBS from among patients referred to the gastroenterology section of our hospital over the last 5 years. The study included a total of 968 patients with an average age of 32 years (range 18-59 years). Females constituted 95% of all patients. Duodenal biopsies were obtained during standard gastroscopy. Sections from these biopsies were stained with haematoxylin and eosin and immunostained for human leucocytes CD45 using the avidin-biotin complex (ABC) method. The sections were then histopathologically examined. Four patients had CD: one with Marsh type 3b, and 3 with Marsh type 1. All four of these patients were positive for tissue transglutminase antibodies (anti-t-TG) IgA and were females aged 24, 20, 36 and 38 years. These 4 patients fulfilled the Rome III criteria for the sub-type IBS-diarrhea. This amounts to a prevalence of 0.4% of CD in IBS patients. The present findings support the notion that IBS patients should be routinely examined for CD. This applies to all subtypes of IBS.

摘要

肠易激综合征(IBS)的诊断基于症状评估,如罗马 III 标准。临床上有时难以将 IBS 与成人发病的乳糜泻(CD)区分开来。表现出相对模糊的腹部症状的 CD 患者有被误诊为 IBS 的风险。本研究旨在调查过去 5 年在我院消化科就诊的符合 IBS 罗马 III 标准的患者中 CD 患者的患病率。该研究共纳入 968 例患者,平均年龄 32 岁(18-59 岁)。所有患者中女性占 95%。在标准胃镜检查期间获取十二指肠活检。用苏木精和曙红以及抗人白细胞 CD45 的免疫组化 ABC 法对这些活检进行染色。然后对切片进行组织病理学检查。4 例患者患有 CD:1 例为 Marsh 3b 型,3 例为 Marsh 1 型。这 4 例患者的组织转谷氨酰胺酶抗体(抗 tTG)IgA 均为阳性,均为 24、20、36 和 38 岁的女性。这 4 例患者符合 IBS-腹泻型的罗马 III 标准。这意味着 IBS 患者中 CD 的患病率为 0.4%。目前的研究结果支持这样一种观点,即应常规检查 IBS 患者的 CD。这适用于所有 IBS 亚型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索